FCIM
GDRX icon

Fairview Capital Investment Management’s GoodRx Holdings GDRX Stock Holding History

Fairview Capital Investment Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,195,458
Closed -$46.6M – 132
2021
Q1 		$46.6M Sell
1,195,458
-315,200
-21% -$14.2M 1.68% 17
2020
Q4 		$60.9M Buy
1,510,658
+985,658
+188% +$45.3M 2.5% 9
2020
Q3 		$29.2M Buy
+525,000
New +$27.8M 1.37% 25

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Fairview Capital Investment Management's GDRX Position: Q2 2021 in Review

Fairview Capital Investment Management sold out of GoodRx Holdings (GDRX) in Q2 2021, closing a stake of 1,195,458 shares — an estimated $46.6M sold.

Fairview Capital Investment Management first reported a position in GDRX in Q3 2020 and held it in 3 quarters. The position peaked at $60.9M in Q4 2020. 199 funds tracked by Wall St. Rank hold GDRX as of Q2 2021.

  • Fairview Capital Investment Management reported no remaining GoodRx Holdings position as of Q2 2021 after selling out during the quarter.
  • Fairview Capital Investment Management sold 1,195,458 GoodRx Holdings shares in Q2 2021, an estimated $46.6M.
  • Fairview Capital Investment Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 3 quarters.
  • Fairview Capital Investment Management's GoodRx Holdings position peaked at $60.9M in Q4 2020.
  • 199 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2021.

Based on Fairview Capital Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.